PBM Rebates Inflate Drug Prices (Shocking), Secret Termination Fees Trap Employers, and Good Doctors Subsidize Malpractice Grifts

Hey all, 

Happy Tuesday! Welcome to another week in American healthcare, where the dominant business model seems entirely predicated on corporate middlemen inventing new, legally sanctioned ways to hold your money hostage. Whether it's Pharmacy Benefit Managers jacking up drug list prices just to fund their own secret rebates or burying punitive exit fees in their contracts to ensure you can never escape, the institutional grift is functioning flawlessly. Throw in the fact that squeaky-clean independent physicians are being forced to bankroll the malpractice premiums of the industry's worst doctors just to pad an insurance executive's stock portfolio, and you really have to wonder when we're going to stop volunteering as an unpaid charity for the healthcare cartel.

Enjoy the rundown! 

Jacob Brody (Co-Founder & CEO, ZorroRX)

[Ditto & Associates] The Lock That Seals Your Fate

A recent analysis of Pharmacy Benefit Manager (PBM) agreements reveals that 52% of contracts utilize intentionally restrictive termination clauses, such as undisclosed wind-down fees and rebate forfeitures, to make switching vendors financially prohibitive. However, 26% of the market now offers clean, fiduciary-aligned exit terms, proving that fair and calculable termination provisions are readily achievable for employers who know to ask. Because these hidden lock-in tactics effectively nullify a plan sponsor's ERISA obligation to monitor and replace underperforming vendors, employers must actively demand transparent contracts to preserve their legal leverage and protect plan assets. 

Full Article

[USC Schaeffer Center] The Association Between Drug Rebates and List Prices

Recent analysis reveals a strong positive correlation between pharmaceutical list prices and the rebates paid to pharmacy benefit managers (PBMs), with every $1 increase in rebates associated with a $1.17 increase in a drug's list price. This near dollar-for-dollar relationship remains robust across various drug classes and is especially pronounced for single-source medications that lack generic competition. Shockingly, it turns out that letting corporate middlemen demand ever-larger secret cuts directly drives up the price of medicine, a profound revelation that surely stuns absolutely no one who has ever interacted with the American healthcare system. 

Full Article

[The Rojas Report] Medical Malpractice Insurance Exploitation

Despite a 55.7% decrease in the frequency of paid medical malpractice claims over the past thirty years, commercial insurance carriers have continuously raised physician premiums for seven consecutive years. These carriers intentionally force the vast majority of physicians with clean records to cross-subsidize the 1% of doctors who generate a third of all claims, allowing insurers to capture massive underwriting profits and investment income on held premiums. By switching to a physician-owned captive insurance model, independent practices can fundamentally disrupt this grift and retain their own profits, because doctors are finally figuring out that acting as a charitable foundation for an insurance executive's stock portfolio isn't actually a medical requirement. 

Full Article